Molecular Quality Control Market is Expected to Reach US$ 11,129.1 Mn at a 24.2% CAGR By 2027 | Huge Growth Expected in Molecular Quality Control in Future

Global Molecular Quality Control Market – Insights

Molecular quality control tests molecular diagnostic products. It also recognizes defects and monitors the efficacy of in vitro nucleic acid testing procedures for viral load assays and healthcare-associated infections (HAIs) such as bloodstream infections, urinary tract infections, pneumonia, and sexually transmitted diseases.

Global Molecular Quality Control Market: Drivers

Increasing launch of new products is expected to propel growth of the global molecular quality control market over the forecast period. For instance, in April 2019, Bruker Corporation BRKR launched the new MALDI Biotyper sirius system for all previously FDA-approved assays and research-use-only (RUO) MALDI Biotyper (MBT) reference libraries. Similarly, in July 2016, Bio-Rad Laboratories, Inc. launched Amplichek Quality Control, a quality control system for molecular diagnostic testing of infectious diseases.

Global Molecular Quality Control Market: Restraints

Molecular quality control systems are prone to inaccurate genetic tests, which is expected to limit growth of the global molecular quality control market. For instance, in August 2017, Invitae Corporation identified a quality control issue with a hereditary cancer test conducted on patients suffering from a rare genetic variant in the MSH2 gene, which is associated with the Lynch syndrome. The test provided false, negative results.

Request for PDF Brochure Here: https://www.coherentmarketinsights.com/insight/request-pdf/2491

Global Molecular Quality Control Market: Regional Analysis

North America is expected to account for the largest market share in the global molecular quality control market over the forecast period. This is attributed to increasing launches of new products. For instance, in December 2018, Microbiologics, Inc. launched two new panels, Group A Streptococcus (GAS) and respiratory molecular assays, for quality control processes. These two panels include convenient features such as multiplexed pellets, swabs that mimic patient sample processing, and room temperature storage.

The market in Asia Pacific is driven by increasing partnership activities by key players. For instance, in June 2016, Thermo Fisher Scientific Inc. partnered with West China Hospital of Sichuan University to improve R&D and diagnostics in pathology.

Global Molecular Quality Control Market: Competitive Landscape

Major players operating in the global molecular quality control market include, Seracare Life Sciences, Inc., Zeptometrix, Thermo Fisher Scientific, Abbott Laboratories, Maine Molecular Quality Controls, Inc., Quidel, Qnostics, Bio-Rad Laboratories, Roche Diagnostics, Microbiologics, Inc., and Theranostica.

Global Molecular Quality Control Market: Key Developments

Major players in the market are focused on adopting collaboration and partnership strategies to expand their product portfolio, For instance, in February 2018, Randox Laboratories partnered with Qnostics to access to the Qnostics molecular range of products for sales and distribution purposes.

Get FLAT USD 2000 OFF

Buy-Now this research report: https://www.coherentmarketinsights.com/promo/buynow/2491

Reasons to Purchase this Report:

Current and future of global Molecular Quality Control Market outlook in the developed and emerging markets

The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.

Regions/countries that are expected to witness the fastest growth rates during the forecast period.

The latest developments, market shares, and strategies that are employed by the major market players.

Global Molecular Quality Control Market Taxonomy

By Product Type

• Independent Control
• Instrument Specific- Control
• DNA Sequencing and NGS (Next Generation Sequencing)
• PCR (Polymer Chain Reaction)
• Others

By Analyte Type

• Single Analyte
• Multi Analyte

By Application

• Oncology
• Genetic Testing
• Infectious Diseases
• Others

By End User

• Clinical Laboratories
• Hospitals and Clinics
• Academic and Research Institutes
• IVD Manufacturers
• Contract Research Organizations
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837